Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome

Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome have?

Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome published?

Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome has 2024 year in the ScholarIQ index.

What is the open-access status of Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome?

Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome has closed oa status in the ScholarIQ index.

What is the DOI of Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome?

The DOI for Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome is on the source record.

What is the OpenAlex record for Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome?

The OpenAlex for Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome is on the source record.